NovaBoneĀ® boosts the body's ability to signal, recruit, proliferate and differentiate bone building cells.
This bioactive technology platform is only available through NovaBone.
NovaBone's bone graft substitute is engineered to accelerate the body's natural healing process with a measured release of ions and changes in surface chemistry that supercharge cellular activity with preferential development of cells that form new bone.

The FDA authorized our use of the term osteostimulation to define this unique process.

Numerous studies, including human clinical trials, have proven that NovaBone demonstrates equivalent rates of bone growth when compared to autogenous bone graft.